Gro-Vida

Gro-Vida is a privately held pharmaceutical company licenced for the cultivation of medical cannabis. Since 2019, Gro-Vida has been operational as one of the pioneering entities to receive licensing for the cultivation of medical cannabis in Portugal, following legalization in 2018. The company owns and operates a 20,000m2 hybridized greenhouse allowing for year-round cultivation to meet the growing demand in the global cannabis market. Gro-Vida is a leader in the cultivation, production and manufacturing of the highest quality cannabinoid-based medicines, supplying pharmaceutical partners throughout the United Kingdom, European Union and Australia. Gro-Vida provides GACP and EU-GMP certified products to the global market, ensuring the highest standards of quality, safety, and efficacy to its partners.